Hennion & Walsh Asset Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,745
Closed -$262K 805
2023
Q1
$262K Sell
8,745
-288
-3% -$9.49K 0.02% 682
2022
Q4
$277K Sell
9,033
-7,976
-47% -$239K 0.02% 651
2022
Q3
$419K Sell
17,009
-775
-4% -$25.6K 0.03% 521
2022
Q2
$569K Sell
17,784
-351
-2% -$12.9K 0.04% 456
2022
Q1
$571K Sell
18,135
-1,166
-6% -$36.5K 0.03% 486
2021
Q4
$648K Buy
19,301
+266
+1% +$8.29K 0.03% 474
2021
Q3
$553K Buy
19,035
+2,341
+14% +$75.8K 0.03% 494
2021
Q2
$581K Buy
+16,694
New +$553K 0.03% 488

Other funds holding CC

Hennion & Walsh Asset Management's CC Position: Q2 2023 in Review

Hennion & Walsh Asset Management sold out of Chemours (CC) in Q2 2023, closing a stake of 8,745 shares — an estimated $262K sold.

Hennion & Walsh Asset Management first reported a position in CC in Q2 2021 and held it in 8 quarters. The position peaked at $648K in Q4 2021. 476 funds tracked by Wall St. Rank hold CC as of Q2 2023.

  • Hennion & Walsh Asset Management reported no remaining Chemours position as of Q2 2023 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 8,745 Chemours shares in Q2 2023, an estimated $262K.
  • Hennion & Walsh Asset Management first reported a position in Chemours in Q2 2021 and held it in 8 quarters.
  • Hennion & Walsh Asset Management's Chemours position peaked at $648K in Q4 2021.
  • 476 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.